Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Holding(s) in Company

17 Dec 2018 15:47

RNS Number : 7316K
Sabien Technology Group PLC
17 December 2018
 

For immediate release

17 December 2018

 

Sabien Technology Group plc("Sabien" or the "Company")

Holding(s) in Company

 

The Board of Sabien announces that the Company has received the following TR-1 notification which is set out below.

 

A copy of this announcement is available on the Company's website at http://www.sabien-tech.co.uk

 

For further information please contact:

 

Sabien Technology Group plc

Alan O'Brien

 

 

Tel: +44(0)20 7993 3700

Beaumont Cornish Limited

Michael Cornish / Roland Cornish

www.beaumontcornish.com

(Nominated Advisor)

 

 

Tel: +44(0)20 7628 3396

Peterhouse Capital Limited

(Broker)

Martin Lampshire and Fungai Ndoro

Tel: +44 (0) 20 7469 0930

 

This announcement is inside information for the purposes of Article 7 of Regulation 596/20014. The person who arranged for the release of this announcement on behalf of the Company was Alan O'Brien, Chief Executive Officer.

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sabien Technology Group plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Amati AIM VCT plc

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

14/12/2018

6. Date on which issuer notified (DD/MM/YYYY):

17/12/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

2.05%

2.05%

590,254,867

Position of previous notification (if

applicable)

6.37%

6.37%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B1FPCD38

12,122,000

2.05%

SUBTOTAL 8. A

12,122,000

2.05%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Edinburgh UK

Date of completion

17/12/2018

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLGGGWCPUPRGAM
Date   Source Headline
2nd May 20253:29 pmRNSNet Asset Value(s)
1st May 20255:31 pmRNSChange of Manager, Change of Name and Board Change
1st May 202510:42 amRNSTotal Voting Rights
25th Apr 20255:00 pmRNSNet Asset Value(s)
23rd Apr 202512:16 pmRNSTransaction in Own Shares
23rd Apr 20259:33 amRNSNet Asset Value(s)
16th Apr 202512:32 pmRNSTransaction in Own Shares
16th Apr 20257:02 amRNSDividend Declaration
16th Apr 20257:01 amRNSAnnual Financial Report
16th Apr 20257:00 amRNSUpdate on Change of Investment Manager
9th Apr 20252:39 pmRNSTransaction in Own Shares
7th Apr 202510:39 amRNSTransaction in Own Shares
4th Apr 20254:46 pmRNSNet Asset Value(s)
4th Apr 20252:32 pmRNSTransaction in Own Shares
3rd Apr 20254:29 pmRNSTransaction in Own Shares
1st Apr 20254:34 pmRNSNet Asset Value(s)
1st Apr 202512:38 pmRNSTotal Voting Rights
31st Mar 20255:00 pmRNSTransaction in Own Shares
26th Mar 20259:57 amRNSTransaction in Own Shares
25th Mar 20258:54 amRNSTransaction in Own Shares
21st Mar 20254:05 pmRNSNet Asset Value(s)
14th Mar 20254:06 pmRNSNet Asset Value(s)
10th Mar 202511:35 amRNSCompliance with Market Abuse Regulation
7th Mar 20254:12 pmRNSNet Asset Value(s)
4th Mar 20254:40 pmRNSTransaction in Own Shares
3rd Mar 20254:18 pmRNSNet Asset Value(s)
3rd Mar 202510:27 amRNSTotal Voting Rights
28th Feb 20253:09 pmRNSTerms of Appointment of New Investment Manager
27th Feb 20254:38 pmRNSTransaction in Own Shares
24th Feb 202512:23 pmRNSNet Asset Value(s)
24th Feb 202510:06 amRNSTransaction in Own Shares
14th Feb 20253:06 pmRNSNet Asset Value(s)
11th Feb 202510:25 amRNSTransaction in Own Shares
7th Feb 20254:50 pmRNSNet Asset Value(s)
3rd Feb 20255:53 pmRNSNet Asset Value(s)
3rd Feb 20259:09 amRNSTotal Voting Rights
24th Jan 20254:36 pmRNSNet Asset Value(s)
24th Jan 20253:02 pmRNSTransaction in Own Shares
20th Jan 202510:04 amRNSNet Asset Value(s)
14th Jan 202510:06 amRNSTransaction in Own Shares
10th Jan 20255:12 pmRNSNet Asset Value(s)
6th Jan 20251:49 pmRNSTransaction in Own Shares
2nd Jan 20255:10 pmRNSNet Asset Value(s)
2nd Jan 202511:41 amRNSTransaction in Own Shares
2nd Jan 202511:15 amRNSTotal Voting Rights
20th Dec 20245:12 pmRNSNet Asset Value(s)
20th Dec 20249:54 amRNSDirector Declaration
13th Dec 20243:41 pmRNSNet Asset Value(s)
12th Dec 20243:37 pmRNSDividend Declaration
11th Dec 202410:51 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.